Clark & Stuart, Inc Repligen Corp Transaction History
Clark & Stuart, Inc
- $137 Billion
- Q4 2024
A detailed history of Clark & Stuart, Inc transactions in Repligen Corp stock. As of the latest transaction made, Clark & Stuart, Inc holds 1,400 shares of RGEN stock, worth $211,022. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,400Holding current value
$211,022% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.08 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$769 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$255 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$233 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.36B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....